Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-05-13

Clinical Trial Update: Cohort Study for Atrial Fibrillation Risk Stratification

View source ↗

Summary

A cohort study at Universitätsklinikum Hamburg-Eppendorf is underway to stratify risk factors for atrial fibrillation and is currently recruiting participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Universitätsklinikum Hamburg-Eppendorf | Conditions: Atrial Fibrillation | Status: RECRUITING